Igraine (AQSE:KING) Deferred Tax : £0.00 Mil (TTM As of . 20)

View and export this data going back to 2008. Start your Free Trial

What is Igraine Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Igraine's change in deferred tax for the six months ended in . 20 was £0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

Igraine Deferred Tax Historical Data

The historical data trend for Igraine's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Igraine Deferred Tax Chart

Igraine Annual Data

Trend

Deferred Tax

Igraine Semi-Annual Data

Deferred Tax

Igraine Deferred Tax Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Deferred Tax for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

Igraine Deferred Tax Related Terms

Thank you for viewing the detailed overview of Igraine's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Igraine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Igraine PLC (AQSE:KING) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Primrose Street, 8th Floor, The Broadgate Tower, London, GBR, EC2A 2EW

Website

https://www.igraineplc.com

Igraine PLC is an investment company. Its business investment is to source and develops breakthrough technologies and commercially attractive discoveries in the health, Medtech, Biotech, and life science sectors.